Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

SFDARegulator guidanceLot release and sample testingBiologicsMedium confidenceLast verified October 13, 2026

SFDA lot release policy

Policy Guidance for Lot Release of Biological Products

Current edition

Version 1.1 of September 1, 2010

About this standard

The SFDA lot release testing program for biological products before sale in Saudi Arabia, before and after approval.

Recognition by market

Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts

No market listing is published yet.

Testing requirements that cite it

Open the market page and its pathway pages for the full requirement, protocol and report content

Saudi Arabia

Related standards: MHRA Responsible Person (import) guidance, EudraLex Volume 4 Annex 16, HC Lot Release Program guidance, TGA vaccine batch release, MFDS imported drug management regulation, MFDS national lot release regulation, RDC 669/2022, RDC 670/2022, RDC 900/2024, RDC 944/2024, Taiwan biological product lot release regulations. See all standards.

Not legal or regulatory advice. Check the current official rules before you act. Parts of the approvals data are official open data reused under open licences. Data sources.

LinkedInLinkedInXXYouTubeYouTube